Conditions treated by medications considered low-priority Other Conditions treated by medications considered low-priority
Conditions
Interventions
Clinical Commissioning Groups (CCGs) will be randomised into the intervention or the control group. Randomisation will take place in software. Those randomised to the intervention group will be invite
Sponsors
NHS England
Eligibility
Inclusion criteria
Inclusion criteria: Clinical Commissioning Groups (CCGs) in England with the highest expenditure on low-priority items per 1000 registered patients.
Exclusion criteria
Exclusion criteria: CCGs where members of the DataLab team are employed or have been recently employed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The following are assessed by the change from the baseline (April to September 2018) to the follow-up (April to September 2019) using a regression model: 1. Cost per 1,000 patients for all 18 pre-specified “low-priority” treatments combined 2. Total items per 1000 across all 18 low priority treatments. | — |
Secondary
| Measure | Time frame |
|---|---|
| Prescribing measures are assessed by the change from the baseline (April to September 2018) to the follow-up (April to September 2019) using a regression model: 3. Cost per 1,000 patients for top 3 pre-specified “low-priority” treatments combined. 4. Total items prescribed per 1000 registered patients for Co-proxamol. 5. Total items prescribed per 1000 registered patients for Dosulepin Engagement measures: 1. Number of page views over one month on CCG page showing low-priority measures, assessed using web page views data from Google analytics, as the change from the baseline for 1 month before/after and change between April to September 2018 and April to September 2019 2. Number of page views over one month on practice pages showing low-priority measures, grouped up to CCGs, assessed using web page views data from Google analytics, as the change from the baseline for 1 month before/after and change between April to September 2018 and April to September 2019 3. Number of registrations to OpenPrescribing CCG email alerts alerts, assessed by counting new email sign-ups within 3 months of the intervention (compared between the intervention and control groups) 4. Number of registrations to OpenPrescribing Practice email alerts grouped up to CCG, assessed by counting new email sign-ups within 3 months of the intervention (compared between the intervention and control groups) Other: Change in number of CCGs with guidance included in workplans, assessed via an NHS England survey pre-session (2017-2018) and 6 months later (2018-2019) using basic descriptive statistics | — |
Countries
England, United Kingdom
Outcome results
None listed